Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: A case report and plan for management

Journal of Vascular Surgery

Volumn 49, Issue 4, 2009, Pages 1037-1040

  Thakur, Subhash ^a   Pigott, John P ^a   Comerota, Anthony J ^a,b  

^a TOLEDO HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; ENOXAPARIN; HEPARIN; POLITEF; WARFARIN;

ADD ON THERAPY; AGED; ANAMNESIS; ANEURYSM; ANTICOAGULANT THERAPY; ARTERY PROSTHESIS; ARTICLE; BLOOD ANALYSIS; BYPASS SURGERY; CASE REPORT; CHRONIC KIDNEY FAILURE; DEVICE REMOVAL; DISEASE SEVERITY; DRUG WITHDRAWAL; FOOT EDEMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEG EDEMA; LEG REVASCULARIZATION; MALE; POPLITEAL ARTERY; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; DEVICE REMOVAL; HEPARIN; HUMANS; LOWER EXTREMITY; MALE; PERIPHERAL VASCULAR DISEASES; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; REOPERATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 63049087881     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.12.004     Document Type: Article

References (16)

1. ® compendium (2002), Carmeda, Upplands Väsby, Sweden. http://www.carmeda.se/upl/files/639.pdf Accessed Aug 12, 2008
2. Begovac P.C., Thomson R.C., Fisher J.L., Hughson A., and Gallhagen A. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg 25 (2003) 432-437
3. Bosiers M., Deloose K., Verbist J., Schroe H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 43 (2006) 313-318
4. Walluscheck K.P., Bierkandt S., Brandt M., and Cremer J. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg (Torino) 46 (2005) 425-430
5. Lilly M.P., Flinn W.R., McCarthy III W.J., Courtney D.F., Yao J.S., and Bergan J.J. The effect of distal arterial anatomy on the success of popliteal aneurysm repair. J Vasc Surg 7 (1988) 653-660
6. Arepally G.M., and Ortel T.L. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355 (2006) 809-817
7. Warkentin T.E., Greinacher A., Koster A., and Lincoff A.M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 340S-380S
8. Warkentin T.E., Levine M.N., Hirsh J., Horsewood P., Roberts R.S., Gent M., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332 (1995) 1330-1335
9. Kelton J.G., Sheridan D., Santos A., Smith J., Steeves K., Smith C., et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 72 (1988) 925-930
10. Chong B.H., Fawaz I., Chesterman C.N., and Berndt M.C. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73 (1989) 235-240
11. Amiral J., Bridey F., Dreyfus M., Vissoc A.M., Fressinaud E., Wolf M., et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68 (1992) 95-96
12. Heyligers J.M., Lisman T., Verhagen H.J., Weeterings C., de Groot P.G., and Moll F.L. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. J Vasc Surg 47 (2008) 324-329
13. ® Ventricular Assist Device after 855 days in a patient (2007) Abstract presented at the 32nd Society for Biomaterials Annual Meeting, Chicago Ill; Apr 18-21. Abstract 180
14. Martel N., Lee J., and Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106 (2005) 2710-2715
15. Lindhoff-Last E., Nakov R., Misselwitz F., Breddin H.K., and Bauersachs R. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol 118 (2002) 1137-1142
16. Suh J.S., Aster R.H., and Visentin G.P. Antibodies from patients wit heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood 91 (1998) 916-922